| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REATA PHARMACEUTICALS INC | Director | Class A common stock | 0 | $172.03 | 26 Sep 2023 | Direct | |
| REATA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | $73.68 | 26 Sep 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RETA | REATA PHARMACEUTICALS INC | 26 Sep 2023 | 8 | $0 | 4 | Director | 26 Sep 2023, 17:30 |
| RETA | REATA PHARMACEUTICALS INC | 28 Jul 2023 | 7 | -$595,620 | 4 | Director | 01 Aug 2023, 16:41 |
| RETA | REATA PHARMACEUTICALS INC | 07 Jun 2023 | 4 | +$242,391 | 4 | Director | 09 Jun 2023, 16:32 |
| RETA | REATA PHARMACEUTICALS INC | 10 Mar 2023 | 7 | -$282,568 | 4 | Director | 13 Mar 2023, 17:23 |
| RETA | REATA PHARMACEUTICALS INC | 08 Jun 2022 | 4 | +$219,941 | 4 | Director | 09 Jun 2022, 16:47 |
| RETA | REATA PHARMACEUTICALS INC | 03 Jan 2022 | 2 | +$6,436 | 4 | Director | 05 Jan 2022, 15:04 |
| RETA | REATA PHARMACEUTICALS INC | 10 Jun 2021 | 2 | +$64,927 | 4 | Director | 14 Jun 2021, 11:33 |